BACKGROUND: There are no robust guidelines on strategies to prevent the adverse skeletal effects of glucocorticoids in children. OBJECTIVES: To evaluate the role of prophylactic calcium and vitamin D on bone health in children with new-onset nephrotic syndrome (NS) treated with short-term (12 weeks), high-doseglucocorticoids. METHODS: Prospective, randomized, controlled, single blind, interventional study conducted on 41 steroid-naïve pre-pubertal children (29 boys, 12 girls). All children received prednisolone for 12 weeks (60 mg/m(2)/day daily for 6 weeks, followed by 40 mg/m(2)/day alternate days for 6 weeks). Recruited children were randomized into the intervention group (IG; vitamin D 1,000 IU/day and elemental calcium 500 mg/day) and the control group (CG). Bone mineral content (BMC) and bone mineral density (BMD) at the lumbar spine (L1-L4) were estimated at baseline and at 12 weeks. Mean percentage changes in BMC and BMD in IG and CG were compared. RESULTS:Children in the IG showed an increase of 11.2 % in BMC versus the CG, who showed an 8.9 % fall (p < 0.0001). Net intervention-attributable difference in BMC was 20.1 %. BMD increased in both groups (IG 2.8 % vs CG 0.74 %), but the difference was not statistically significant (p = 0.27). CONCLUSIONS: Short-term, high-dose glucocorticoid therapy decreases the BMC of the lumbar spine in steroid-naïve children with NS. Vitamin D and calcium co-administration not only prevents this decline, but also enhances BMC of the lumbar spine.
RCT Entities:
BACKGROUND: There are no robust guidelines on strategies to prevent the adverse skeletal effects of glucocorticoids in children. OBJECTIVES: To evaluate the role of prophylactic calcium and vitamin D on bone health in children with new-onset nephrotic syndrome (NS) treated with short-term (12 weeks), high-dose glucocorticoids. METHODS: Prospective, randomized, controlled, single blind, interventional study conducted on 41 steroid-naïve pre-pubertal children (29 boys, 12 girls). All children received prednisolone for 12 weeks (60 mg/m(2)/day daily for 6 weeks, followed by 40 mg/m(2)/day alternate days for 6 weeks). Recruited children were randomized into the intervention group (IG; vitamin D 1,000 IU/day and elemental calcium 500 mg/day) and the control group (CG). Bone mineral content (BMC) and bone mineral density (BMD) at the lumbar spine (L1-L4) were estimated at baseline and at 12 weeks. Mean percentage changes in BMC and BMD in IG and CG were compared. RESULTS:Children in the IG showed an increase of 11.2 % in BMC versus the CG, who showed an 8.9 % fall (p < 0.0001). Net intervention-attributable difference in BMC was 20.1 %. BMD increased in both groups (IG 2.8 % vs CG 0.74 %), but the difference was not statistically significant (p = 0.27). CONCLUSIONS: Short-term, high-dose glucocorticoid therapy decreases the BMC of the lumbar spine in steroid-naïve children with NS. Vitamin D and calcium co-administration not only prevents this decline, but also enhances BMC of the lumbar spine.
Authors: Inge M van der Sluis; Marry M van den Heuvel-Eibrink; Karel Hählen; Eric P Krenning; Sabine M P F de Muinck Keizer-Schrama Journal: J Pediatr Date: 2002-08 Impact factor: 4.406
Authors: L Ward; A C Tricco; P Phuong; A Cranney; N Barrowman; I Gaboury; F Rauch; P Tugwell; D Moher Journal: Cochrane Database Syst Rev Date: 2007-10-17
Authors: Amy J Kogon; Lance S Ballester; Jarcy Zee; Natalie Walker; Joshua J Zaritsky; Meredith A Atkinson; Christine B Sethna; Andrew N Hoofnagle; Mary B Leonard; Michelle R Denburg Journal: Pediatr Nephrol Date: 2022-07-19 Impact factor: 3.651
Authors: David T Selewski; Ashton Chen; Ibrahim F Shatat; Priya Pais; Larry A Greenbaum; Pavel Geier; Raoul D Nelson; Stefan G Kiessling; Patrick D Brophy; Alejandro Quiroga; Michael E Seifert; Caroline E Straatmann; John D Mahan; Maria E Ferris; Jonathan P Troost; Debbie S Gipson Journal: Pediatr Nephrol Date: 2015-10-23 Impact factor: 3.714